As Rictor is a key component of mTORC2, we assessed the RPPA dataset of invasive breast cancers (TCGA) to determine whether RICTOR gene expression or amplification correlates with increased mTORC2 signaling in clinical tumor specimens. The gene discussed is RICTOR; the disease is neoplasm.